Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim Alexandre

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
JAMA Cardiology|July 7, 2021
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative ReviewLorenz H Lehmann, Jennifer Cautela, Nicolas Palaskas, et al.
Archives of Cardiovascular Diseases|May 20, 2022
Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditisJohn R Power, Joachim Alexandre, Arrush Choudhary, et al.
Fundamental & Clinical Pharmacology|May 13, 2020
Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemicLouis Larrouquere, Manon Gabin, Emmanuelle Poingt, et al.
British Journal of Haematology|October 6, 2021
Poly(ADP-ribose)polymerase inhibitors-associated myeloid neoplasms: a retrospective study from the French Network of Pharmacovigilance centresPierre-Marie Morice, Alexis Genthon, Thomas Boyer, et al.
Nature Medicine|November 27, 2023
Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditisCharlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
Nature Medicine|January 3, 2024
Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditisCharlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
Nature Medicine|October 26, 2023
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditisCharlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
European Heart Journal|June 26, 2025
Immune checkpoint inhibitor-associated myocarditis: a novel risk scoreJohn R Power, Charles Dolladille, Benay Ozbay, et al.
JACC. Cardiooncology|April 17, 2025
Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic DysfunctionYen-Chou Chen, Charles Dolladille, Anjali Rao, et al.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis SeverityJohn R Power, Charles Dolladille, Benay Ozbay, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
JAMA Cardiology|July 7, 2021
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative ReviewLorenz H Lehmann, Jennifer Cautela, Nicolas Palaskas, et al.
Archives of Cardiovascular Diseases|May 20, 2022
Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditisJohn R Power, Joachim Alexandre, Arrush Choudhary, et al.
Fundamental & Clinical Pharmacology|May 13, 2020
Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemicLouis Larrouquere, Manon Gabin, Emmanuelle Poingt, et al.
British Journal of Haematology|October 6, 2021
Poly(ADP-ribose)polymerase inhibitors-associated myeloid neoplasms: a retrospective study from the French Network of Pharmacovigilance centresPierre-Marie Morice, Alexis Genthon, Thomas Boyer, et al.
Nature Medicine|November 27, 2023
Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditisCharlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
Nature Medicine|January 3, 2024
Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditisCharlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
Nature Medicine|October 26, 2023
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditisCharlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
European Heart Journal|June 26, 2025
Immune checkpoint inhibitor-associated myocarditis: a novel risk scoreJohn R Power, Charles Dolladille, Benay Ozbay, et al.
JACC. Cardiooncology|April 17, 2025
Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic DysfunctionYen-Chou Chen, Charles Dolladille, Anjali Rao, et al.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis SeverityJohn R Power, Charles Dolladille, Benay Ozbay, et al.
Pageof 15